We’re charting the course from population to precision health.› Learn More
News & Events
22 May 2018Health Outcomes & Technology Company OM1 Closes $21 Million Series B Financing and Expands Product Offerings
Demonstrating Treatment Benefit and Value in Rheumatology & Immunology
Join us for a webinar on using big data, AI and curated registries for accessing important outcomes in rheumatology and immunology and using them to demonstrate comparative effectiveness and value.
Findings from a Real-World Cohort: Rheumatology & Cardiovascular
This report covers examples of big data and machine learning applications in evaluating real-world outcomes in rheumatology and cardiovascular disease, including six published results.